id	sid	eid	entity	type
ihlr-28381	1	1	indiana health law review	ORG
ihlr-28381	1	2	2024	CARDINAL
ihlr-28381	1	3	1	CARDINAL
ihlr-28381	1	4	thomas abrams* i.	PERSON
ihlr-28381	13	1	first	ORDINAL
ihlr-28381	14	1	the food and drug administration	ORG
ihlr-28381	14	2	fda	ORG
ihlr-28381	14	3	1	CARDINAL
ihlr-28381	14	4	2	CARDINAL
ihlr-28381	14	5	3	CARDINAL
ihlr-28381	14	6	4	CARDINAL
ihlr-28381	14	7	2024	DATE
ihlr-28381	14	8	indiana	GPE
ihlr-28381	14	9	robert h. mckinney school	PERSON
ihlr-28381	14	10	b.s.	GPE
ihlr-28381	14	11	2021	DATE
ihlr-28381	14	12	university of dayton	ORG
ihlr-28381	15	1	aila hoss	PERSON
ihlr-28381	15	2	jake butz	PERSON
ihlr-28381	16	1	122	CARDINAL
ihlr-28381	16	2	indiana health law review	ORG
ihlr-28381	20	1	two	CARDINAL
ihlr-28381	24	1	the federal trade commission	ORG
ihlr-28381	24	2	ftc	ORG
ihlr-28381	24	3	7	CARDINAL
ihlr-28381	24	4	20	CARDINAL
ihlr-28381	24	5	ftc	ORG
ihlr-28381	24	6	218	CARDINAL
ihlr-28381	24	7	66	CARDINAL
ihlr-28381	25	1	66	CARDINAL
ihlr-28381	25	2	as much as 90%	PERCENT
ihlr-28381	26	1	300	MONEY
ihlr-28381	26	2	as little as $30	MONEY
ihlr-28381	28	1	1	CARDINAL
ihlr-28381	28	2	u.s. food & drug admin	ORG
ihlr-28381	29	1	2017	CARDINAL
ihlr-28381	30	1	2	CARDINAL
ihlr-28381	30	2	u.s.	GPE
ihlr-28381	31	1	ftc	ORG
ihlr-28381	31	2	25	CARDINAL
ihlr-28381	33	1	3	CARDINAL
ihlr-28381	33	2	u.s.	GPE
ihlr-28381	34	1	billions, 4 (	PERCENT
ihlr-28381	34	2	2010	DATE
ihlr-28381	36	1	4	CARDINAL
ihlr-28381	38	1	1	CARDINAL
ihlr-28381	38	2	123	CARDINAL
ihlr-28381	39	1	u.s.	GPE
ihlr-28381	39	2	8%	PERCENT
ihlr-28381	39	3	29%	PERCENT
ihlr-28381	39	4	u.s.	GPE
ihlr-28381	40	1	nearly 30%	PERCENT
ihlr-28381	40	2	americans	NORP
ihlr-28381	40	3	half	CARDINAL
ihlr-28381	40	4	approximately 8%	PERCENT
ihlr-28381	40	5	u.s.	GPE
ihlr-28381	41	1	19	CARDINAL
ihlr-28381	43	1	6	CARDINAL
ihlr-28381	44	1	nearly 1	CARDINAL
ihlr-28381	44	2	4	CARDINAL
ihlr-28381	44	3	americans	NORP
ihlr-28381	46	1	7	CARDINAL
ihlr-28381	49	1	124	CARDINAL
ihlr-28381	49	2	indiana health law review	ORG
ihlr-28381	50	1	one	CARDINAL
ihlr-28381	50	2	fda	ORG
ihlr-28381	51	1	each year	DATE
ihlr-28381	51	2	u.s.	GPE
ihlr-28381	51	3	billions of dollars	MONEY
ihlr-28381	51	4	cost.10	GPE
ihlr-28381	51	5	annual	DATE
ihlr-28381	51	6	$3.5 billion	MONEY
ihlr-28381	51	7	37	MONEY
ihlr-28381	51	8	six	CARDINAL
ihlr-28381	51	9	robin feldman	PERSON
ihlr-28381	51	10	$19.2 billion	MONEY
ihlr-28381	51	11	about 7%	PERCENT
ihlr-28381	51	12	annual	DATE
ihlr-28381	51	13	u.s.	GPE
ihlr-28381	51	14	feldman	PERSON
ihlr-28381	55	1	two	CARDINAL
ihlr-28381	55	2	1	CARDINAL
ihlr-28381	55	3	fda	ORG
ihlr-28381	55	4	2	CARDINAL
ihlr-28381	56	1	prv	PERSON
ihlr-28381	57	1	fda	ORG
ihlr-28381	59	1	prv	PERSON
ihlr-28381	60	1	prv	PERSON
ihlr-28381	63	1	congress	ORG
ihlr-28381	63	2	10	CARDINAL
ihlr-28381	64	1	robin c. feldman	PERSON
ihlr-28381	64	2	23	CARDINAL
ihlr-28381	65	1	sci. & tech	ORG
ihlr-28381	66	1	l. rev	PERSON
ihlr-28381	66	2	1	CARDINAL
ihlr-28381	66	3	32	CARDINAL
ihlr-28381	66	4	2022	CARDINAL
ihlr-28381	66	5	5ftm	CARDINAL
ihlr-28381	67	1	11	CARDINAL
ihlr-28381	70	1	17	CARDINAL
ihlr-28381	71	1	14	CARDINAL
ihlr-28381	73	1	125	CARDINAL
ihlr-28381	74	1	first	ORDINAL
ihlr-28381	74	2	two	CARDINAL
ihlr-28381	74	3	two	CARDINAL
ihlr-28381	76	1	ftc	ORG
ihlr-28381	76	2	the supreme court	ORG
ihlr-28381	79	1	u.s.	GPE
ihlr-28381	85	1	first	ORDINAL
ihlr-28381	86	1	merck & co.	ORG
ihlr-28381	86	2	bristol myers squibb	ORG
ihlr-28381	88	1	nih	ORG
ihlr-28381	88	2	over $100 billion dollars	MONEY
ihlr-28381	88	3	210	CARDINAL
ihlr-28381	88	4	fda	ORG
ihlr-28381	88	5	2010–2016.16	CARDINAL
ihlr-28381	88	6	16	CARDINAL
ihlr-28381	89	1	ekaterina galkina cleary et al	PERSON
ihlr-28381	89	2	nih	ORG
ihlr-28381	89	3	2010-2016	DATE
ihlr-28381	89	4	sci.	ORG
ihlr-28381	90	1	2018	DATE
ihlr-28381	92	1	126	CARDINAL
ihlr-28381	92	2	indiana health law review	ORG
ihlr-28381	92	3	programs.17	ORG
ihlr-28381	93	1	fda	ORG
ihlr-28381	94	1	drug.18	ORG
ihlr-28381	94	2	fda	ORG
ihlr-28381	95	1	twenty years	DATE
ihlr-28381	95	2	only seven	CARDINAL
ihlr-28381	95	3	only 12%	PERCENT
ihlr-28381	95	4	one	CARDINAL
ihlr-28381	95	5	one	CARDINAL
ihlr-28381	95	6	two billion dollars.20	MONEY
ihlr-28381	98	1	teva	GPE
ihlr-28381	98	2	reddy	PERSON
ihlr-28381	98	3	fresenius kabi	PERSON
ihlr-28381	99	1	fda	ORG
ihlr-28381	101	1	first	ORDINAL
ihlr-28381	101	2	approximately 20%.21	CARDINAL
ihlr-28381	101	3	85%	PERCENT
ihlr-28381	101	4	17	CARDINAL
ihlr-28381	102	1	18	CARDINAL
ihlr-28381	103	1	v. actavis	PERSON
ihlr-28381	103	2	inc.	ORG
ihlr-28381	103	3	570	CARDINAL
ihlr-28381	103	4	u.s. 136	GPE
ihlr-28381	103	5	148	CARDINAL
ihlr-28381	103	6	2013	DATE
ihlr-28381	104	1	19	CARDINAL
ihlr-28381	104	2	jan berger et al.	PERSON
ihlr-28381	104	3	22	CARDINAL
ihlr-28381	105	1	j. manag	PERSON
ihlr-28381	105	2	2016	CARDINAL
ihlr-28381	106	1	nih.gov/28719222/	PERSON
ihlr-28381	108	1	20	CARDINAL
ihlr-28381	109	1	cong	PERSON
ihlr-28381	110	1	57025	DATE
ihlr-28381	110	2	2	CARDINAL
ihlr-28381	110	3	14	DATE
ihlr-28381	110	4	17	CARDINAL
ihlr-28381	110	5	2021	CARDINAL
ihlr-28381	112	1	21	CARDINAL
ihlr-28381	113	1	robin feldman & evan	ORG
ihlr-28381	113	2	53	CARDINAL
ihlr-28381	114	1	j. legis	PERSON
ihlr-28381	115	1	499	CARDINAL
ihlr-28381	115	2	500-501	CARDINAL
ihlr-28381	115	3	2016	DATE
ihlr-28381	118	1	22	CARDINAL
ihlr-28381	119	1	u.s. food & drug admin	ORG
ihlr-28381	119	2	127	CARDINAL
ihlr-28381	120	1	more than 10,000	CARDINAL
ihlr-28381	120	2	90%	PERCENT
ihlr-28381	120	3	nine	CARDINAL
ihlr-28381	120	4	ten	CARDINAL
ihlr-28381	120	5	18%	PERCENT
ihlr-28381	120	6	90%	PERCENT
ihlr-28381	120	7	only 18%	PERCENT
ihlr-28381	120	8	2020	DATE
ihlr-28381	120	9	$338 billion	MONEY
ihlr-28381	120	10	billions of dollars	MONEY
ihlr-28381	120	11	annually	DATE
ihlr-28381	123	1	generics	PERSON
ihlr-28381	126	1	one	CARDINAL
ihlr-28381	128	1	more than two	CARDINAL
ihlr-28381	128	2	bush	PERSON
ihlr-28381	129	1	hatch-waxman &	ORG
ihlr-28381	129	2	1984	DATE
ihlr-28381	129	3	congress	ORG
ihlr-28381	129	4	hatch-waxman	ORG
ihlr-28381	129	5	market.27	GPE
ihlr-28381	129	6	19%	PERCENT
ihlr-28381	129	7	35%	PERCENT
ihlr-28381	129	8	today	DATE
ihlr-28381	129	9	90%	PERCENT
ihlr-28381	129	10	nov. 2021	DATE
ihlr-28381	130	1	23	CARDINAL
ihlr-28381	131	1	u.s. food & drug admin	ORG
ihlr-28381	131	2	2021	CARDINAL
ihlr-28381	131	3	annual	DATE
ihlr-28381	131	4	2	CARDINAL
ihlr-28381	131	5	9	CARDINAL
ihlr-28381	131	6	2022	CARDINAL
ihlr-28381	133	1	24	CARDINAL
ihlr-28381	134	1	2	CARDINAL
ihlr-28381	134	2	25	CARDINAL
ihlr-28381	135	1	26	CARDINAL
ihlr-28381	135	2	21	CARDINAL
ihlr-28381	136	1	355	CARDINAL
ihlr-28381	136	2	2022	CARDINAL
ihlr-28381	137	1	27	CARDINAL
ihlr-28381	138	1	hatch-waxman	ORG
ihlr-28381	138	2	phrma	PERSON
ihlr-28381	138	3	2018	DATE
ihlr-28381	140	1	28	CARDINAL
ihlr-28381	141	1	d.	NORP
ihlr-28381	141	2	128	CARDINAL
ihlr-28381	141	3	indiana health law review	ORG
ihlr-28381	142	1	over 80%	PERCENT
ihlr-28381	143	1	infringement.30	NORP
ihlr-28381	143	2	years	DATE
ihlr-28381	144	1	hatch-waxman	ORG
ihlr-28381	145	1	31	CARDINAL
ihlr-28381	146	1	hatch-waxman	ORG
ihlr-28381	146	2	first	ORDINAL
ihlr-28381	146	3	180-day	DATE
ihlr-28381	146	4	period.33	ORG
ihlr-28381	146	5	180 days	DATE
ihlr-28381	147	1	six months	DATE
ihlr-28381	149	1	between 2009 and 2019	DATE
ihlr-28381	149	2	u.s.	GPE
ihlr-28381	149	3	billions	CARDINAL
ihlr-28381	152	1	a. hatch-waxman	PERSON
ihlr-28381	152	2	29	CARDINAL
ihlr-28381	154	1	roche prod.	ORG
ihlr-28381	154	2	v. bolar pharm.	ORG
ihlr-28381	155	1	733	CARDINAL
ihlr-28381	155	2	858	CARDINAL
ihlr-28381	155	3	fed	ORG
ihlr-28381	155	4	cir	ORG
ihlr-28381	155	5	1984	DATE
ihlr-28381	156	1	31	CARDINAL
ihlr-28381	156	2	35	CARDINAL
ihlr-28381	157	1	271(e)(1	CARDINAL
ihlr-28381	158	1	32	CARDINAL
ihlr-28381	158	2	21	CARDINAL
ihlr-28381	159	1	2022	CARDINAL
ihlr-28381	160	1	33	CARDINAL
ihlr-28381	161	1	34	CARDINAL
ihlr-28381	162	1	feldman & frondorf	ORG
ihlr-28381	162	2	21	CARDINAL
ihlr-28381	162	3	500-03	QUANTITY
ihlr-28381	163	1	35	CARDINAL
ihlr-28381	164	1	generic drug	ORG
ihlr-28381	164	2	22	CARDINAL
ihlr-28381	165	1	36	CARDINAL
ihlr-28381	166	1	feldman	PERSON
ihlr-28381	166	2	supra	PERSON
ihlr-28381	166	3	10	CARDINAL
ihlr-28381	166	4	32	CARDINAL
ihlr-28381	166	5	2024	CARDINAL
ihlr-28381	166	6	129	CARDINAL
ihlr-28381	166	7	anda”).37 andas	WORK_OF_ART
ihlr-28381	167	1	20 days	DATE
ihlr-28381	167	2	certification.39	ORG
ihlr-28381	169	1	fda	ORG
ihlr-28381	169	2	anda	PERSON
ihlr-28381	169	3	30 months	DATE
ihlr-28381	169	4	1	CARDINAL
ihlr-28381	169	5	2	CARDINAL
ihlr-28381	170	1	second	ORDINAL
ihlr-28381	173	1	ftc	ORG
ihlr-28381	177	1	37	CARDINAL
ihlr-28381	177	2	21	CARDINAL
ihlr-28381	178	1	355	CARDINAL
ihlr-28381	178	2	2022	CARDINAL
ihlr-28381	179	1	38	CARDINAL
ihlr-28381	181	1	39	CARDINAL
ihlr-28381	183	1	40	CARDINAL
ihlr-28381	184	1	355	CARDINAL
ihlr-28381	185	1	41	CARDINAL
ihlr-28381	186	1	feldman & frondorf	ORG
ihlr-28381	186	2	21	CARDINAL
ihlr-28381	186	3	509	CARDINAL
ihlr-28381	187	1	42	CARDINAL
ihlr-28381	188	1	kevin t. richards et al.	PERSON
ihlr-28381	190	1	130	CARDINAL
ihlr-28381	190	2	indiana health law review	ORG
ihlr-28381	192	1	secondary	ORDINAL
ihlr-28381	192	2	five	CARDINAL
ihlr-28381	193	1	five mg/kg	QUANTITY
ihlr-28381	194	1	a five mg/kg	QUANTITY
ihlr-28381	195	1	five mg/kg	QUANTITY
ihlr-28381	197	1	ftc	ORG
ihlr-28381	197	2	73%	PERCENT
ihlr-28381	202	1	8	CARDINAL
ihlr-28381	202	2	2020	DATE
ihlr-28381	202	3	https://crsreports.congress.gov/product/pdf/	DATE
ihlr-28381	204	1	43	CARDINAL
ihlr-28381	205	1	u.s.	GPE
ihlr-28381	206	1	ftc	ORG
ihlr-28381	206	2	13	CARDINAL
ihlr-28381	206	3	2002	DATE
ihlr-28381	209	1	brian c. howard	PERSON
ihlr-28381	209	2	hatch-waxman	ORG
ihlr-28381	209	3	2017	DATE
ihlr-28381	209	4	global patent group	ORG
ihlr-28381	209	5	april 2017	DATE
ihlr-28381	210	1	45	CARDINAL
ihlr-28381	210	2	feldman & frondorf	ORG
ihlr-28381	210	3	21	CARDINAL
ihlr-28381	210	4	511	CARDINAL
ihlr-28381	211	1	46	DATE
ihlr-28381	211	2	feldman	PERSON
ihlr-28381	211	3	supra	PERSON
ihlr-28381	211	4	10	CARDINAL
ihlr-28381	211	5	22	CARDINAL
ihlr-28381	211	6	25	DATE
ihlr-28381	211	7	2024	CARDINAL
ihlr-28381	211	8	131	CARDINAL
ihlr-28381	218	1	2013	DATE
ihlr-28381	218	2	ftc	ORG
ihlr-28381	218	3	note).48 contemporary	PRODUCT
ihlr-28381	219	1	ftc	ORG
ihlr-28381	224	1	47	CARDINAL
ihlr-28381	225	1	feldman & frondorf	ORG
ihlr-28381	225	2	21	CARDINAL
ihlr-28381	225	3	511	CARDINAL
ihlr-28381	226	1	48	DATE
ihlr-28381	227	1	516	CARDINAL
ihlr-28381	227	2	49	CARDINAL
ihlr-28381	228	1	jamie towey	PERSON
ihlr-28381	228	2	brad albert	PERSON
ihlr-28381	228	3	ftc v. actavis	ORG
ihlr-28381	228	4	may 28, 2019	DATE
ihlr-28381	231	1	50	CARDINAL
ihlr-28381	232	1	impax labs.	PERSON
ihlr-28381	232	2	v. ftc	PERSON
ihlr-28381	232	3	994	CARDINAL
ihlr-28381	232	4	484	CARDINAL
ihlr-28381	232	5	493	CARDINAL
ihlr-28381	232	6	5th	ORDINAL
ihlr-28381	232	7	2021	CARDINAL
ihlr-28381	233	1	51	CARDINAL
ihlr-28381	234	1	laura karas et al.	PERSON
ihlr-28381	234	2	71	CARDINAL
ihlr-28381	234	3	hastings l.j	PERSON
ihlr-28381	234	4	959	CARDINAL
ihlr-28381	234	5	967	CARDINAL
ihlr-28381	234	6	2020	DATE
ihlr-28381	234	7	132	CARDINAL
ihlr-28381	234	8	indiana health law review	ORG
ihlr-28381	236	1	180-day	DATE
ihlr-28381	236	2	the day	DATE
ihlr-28381	236	3	first	ORDINAL
ihlr-28381	237	1	first	ORDINAL
ihlr-28381	237	2	180-day	DATE
ihlr-28381	237	3	first	ORDINAL
ihlr-28381	238	1	one	CARDINAL
ihlr-28381	240	1	180-day	DATE
ihlr-28381	242	1	180-day	DATE
ihlr-28381	243	1	180-day	DATE
ihlr-28381	247	1	supreme court	ORG
ihlr-28381	247	2	disapproval.52	ORG
ihlr-28381	249	1	congress	ORG
ihlr-28381	251	1	papers.cfm?abstract_id=3458552	NORP
ihlr-28381	252	1	52	CARDINAL
ihlr-28381	253	1	ftc	ORG
ihlr-28381	253	2	inc.	ORG
ihlr-28381	253	3	570	CARDINAL
ihlr-28381	253	4	136	CARDINAL
ihlr-28381	253	5	141	DATE
ihlr-28381	253	6	2013	DATE
ihlr-28381	254	1	53	CARDINAL
ihlr-28381	255	1	litig	PERSON
ihlr-28381	256	1	64	CARDINAL
ihlr-28381	256	2	f. supp	PERSON
ihlr-28381	257	1	2024	CARDINAL
ihlr-28381	257	2	133	CARDINAL
ihlr-28381	258	1	regulations—21	ORG
ihlr-28381	258	2	cfr	PERSON
ihlr-28381	258	3	10.20-30	CARDINAL
ihlr-28381	258	4	fda	ORG
ihlr-28381	263	1	2008 to 2013	DATE
ihlr-28381	263	2	124	CARDINAL
ihlr-28381	263	3	only eight	CARDINAL
ihlr-28381	263	4	6%	PERCENT
ihlr-28381	264	1	fda	ORG
ihlr-28381	264	2	anda	PERSON
ihlr-28381	264	3	fda	ORG
ihlr-28381	264	4	150 days	DATE
ihlr-28381	265	1	150-day	DATE
ihlr-28381	265	2	anda	PERSON
ihlr-28381	265	3	150 days	DATE
ihlr-28381	265	4	hundreds of millions of dollars	MONEY
ihlr-28381	265	5	hundreds of millions of dollars	MONEY
ihlr-28381	266	1	fda	ORG
ihlr-28381	267	1	2018	DATE
ihlr-28381	267	2	delaware district	ORG
ihlr-28381	267	3	ftc	ORG
ihlr-28381	267	4	shire viropharma.58	ORG
ihlr-28381	267	5	ftc	ORG
ihlr-28381	267	6	fda	ORG
ihlr-28381	267	7	24	CARDINAL
ihlr-28381	268	1	the 11th hour	TIME
ihlr-28381	269	1	2015	DATE
ihlr-28381	269	2	bayer healthcare	ORG
ihlr-28381	269	3	3d 665	CARDINAL
ihlr-28381	269	4	679	CARDINAL
ihlr-28381	269	5	2014	DATE
ihlr-28381	269	6	west penn allegheny	ORG
ihlr-28381	269	7	sys.	GPE
ihlr-28381	270	1	upmc	ORG
ihlr-28381	270	2	627	CARDINAL
ihlr-28381	270	3	85	CARDINAL
ihlr-28381	270	4	109	CARDINAL
ihlr-28381	270	5	3rd	ORDINAL
ihlr-28381	270	6	2010	DATE
ihlr-28381	271	1	54	CARDINAL
ihlr-28381	271	2	21	CARDINAL
ihlr-28381	272	1	10.20	CARDINAL
ihlr-28381	272	2	10.30	CARDINAL
ihlr-28381	272	3	2022	CARDINAL
ihlr-28381	273	1	55	CARDINAL
ihlr-28381	274	1	feldman & frondorf	ORG
ihlr-28381	274	2	21	CARDINAL
ihlr-28381	274	3	546	CARDINAL
ihlr-28381	275	1	56	CARDINAL
ihlr-28381	275	2	21	CARDINAL
ihlr-28381	276	1	10.30	CARDINAL
ihlr-28381	276	2	2022	CARDINAL
ihlr-28381	277	1	57	CARDINAL
ihlr-28381	278	1	robin feldman & connie wang	ORG
ihlr-28381	278	2	376	CARDINAL
ihlr-28381	278	3	j. med	PERSON
ihlr-28381	279	1	1499	CARDINAL
ihlr-28381	279	2	1501	CARDINAL
ihlr-28381	279	3	2017	DATE
ihlr-28381	279	4	https://perma.cc/7kqy-yycj	NORP
ihlr-28381	280	1	58	CARDINAL
ihlr-28381	281	1	ftc v. shire viropharma inc.	ORG
ihlr-28381	282	1	17	CARDINAL
ihlr-28381	282	2	2018 wl 1401329	DATE
ihlr-28381	282	3	1	CARDINAL
ihlr-28381	282	4	mar. 20, 2018	DATE
ihlr-28381	282	5	917	CARDINAL
ihlr-28381	282	6	147	CARDINAL
ihlr-28381	282	7	3d	CARDINAL
ihlr-28381	282	8	2019	DATE
ihlr-28381	283	1	59	CARDINAL
ihlr-28381	284	1	d.	NORP
ihlr-28381	284	2	134	CARDINAL
ihlr-28381	284	3	indiana health law review	ORG
ihlr-28381	284	4	one day	DATE
ihlr-28381	284	5	150 days	DATE
ihlr-28381	287	1	invalidated—68%	PERCENT
ihlr-28381	287	2	one	CARDINAL
ihlr-28381	289	1	generic developers.67	ORG
ihlr-28381	290	1	astrazeneca	PERSON
ihlr-28381	290	2	multi-billion dollar	MONEY
ihlr-28381	290	3	example.68	ORDINAL
ihlr-28381	290	4	60	CARDINAL
ihlr-28381	291	1	michael a. carrier &	PERSON
ihlr-28381	291	2	carl minniti	PERSON
ihlr-28381	291	3	66	CARDINAL
ihlr-28381	292	1	u. l. rev	PERSON
ihlr-28381	292	2	305	CARDINAL
ihlr-28381	292	3	309	CARDINAL
ihlr-28381	292	4	346	CARDINAL
ihlr-28381	292	5	2017	CARDINAL
ihlr-28381	293	1	61	CARDINAL
ihlr-28381	293	2	feldman & wang	ORG
ihlr-28381	293	3	supra	PERSON
ihlr-28381	293	4	56	CARDINAL
ihlr-28381	293	5	1501	CARDINAL
ihlr-28381	293	6	feldman & frondorf	ORG
ihlr-28381	293	7	21	CARDINAL
ihlr-28381	293	8	547	CARDINAL
ihlr-28381	293	9	62	CARDINAL
ihlr-28381	294	1	richards et al.	PERSON
ihlr-28381	294	2	41	CARDINAL
ihlr-28381	296	1	feldman	PERSON
ihlr-28381	296	2	supra	PERSON
ihlr-28381	296	3	10	CARDINAL
ihlr-28381	296	4	21	CARDINAL
ihlr-28381	297	1	richards et al.	PERSON
ihlr-28381	297	2	41	CARDINAL
ihlr-28381	298	1	66	CARDINAL
ihlr-28381	299	1	michael a. carrier &	PERSON
ihlr-28381	299	2	steve d. shadowen	PERSON
ihlr-28381	299	3	92	CARDINAL
ihlr-28381	299	4	l. rev	PERSON
ihlr-28381	299	5	167	CARDINAL
ihlr-28381	299	6	169	CARDINAL
ihlr-28381	299	7	2017	CARDINAL
ihlr-28381	301	1	67	CARDINAL
ihlr-28381	302	1	168-69	CARDINAL
ihlr-28381	303	1	68	CARDINAL
ihlr-28381	304	1	alex brill	PERSON
ihlr-28381	304	2	4	CARDINAL
ihlr-28381	304	3	https://www.affordableprescriptiondrugs.org/app/uploads/2020/09/	CARDINAL
ihlr-28381	307	1	135	CARDINAL
ihlr-28381	307	2	13 remaining years	DATE
ihlr-28381	315	1	2015	DATE
ihlr-28381	315	2	martin shkreli	PERSON
ihlr-28381	315	3	17.60	MONEY
ihlr-28381	316	1	ftc	ORG
ihlr-28381	316	2	ftc	ORG
ihlr-28381	317	1	v. shkreli	PERSON
ihlr-28381	318	1	eighteen months	DATE
ihlr-28381	318	2	60 years old	DATE
ihlr-28381	318	3	69	CARDINAL
ihlr-28381	319	1	70	CARDINAL
ihlr-28381	323	1	richards et al.	PERSON
ihlr-28381	323	2	41	CARDINAL
ihlr-28381	325	1	ftc	ORG
ihlr-28381	325	2	581	CARDINAL
ihlr-28381	325	3	f. supp	PERSON
ihlr-28381	326	1	3d 579	CARDINAL
ihlr-28381	326	2	601	CARDINAL
ihlr-28381	326	3	2022	CARDINAL
ihlr-28381	327	1	75	CARDINAL
ihlr-28381	328	1	136	CARDINAL
ihlr-28381	328	2	indiana health law review	ORG
ihlr-28381	328	3	18-month	DATE
ihlr-28381	328	4	almost $65 million	MONEY
ihlr-28381	328	5	fda	ORG
ihlr-28381	328	6	fda	ORG
ihlr-28381	328	7	anda	PERSON
ihlr-28381	328	8	anda	PERSON
ihlr-28381	328	9	daraprim	ORG
ihlr-28381	328	10	d.	NORP
ihlr-28381	329	1	today	DATE
ihlr-28381	332	1	76	CARDINAL
ihlr-28381	333	1	590	CARDINAL
ihlr-28381	335	1	591	CARDINAL
ihlr-28381	337	1	633-34	CARDINAL
ihlr-28381	337	2	79	CARDINAL
ihlr-28381	338	1	595-96	CARDINAL
ihlr-28381	338	2	80	CARDINAL
ihlr-28381	339	1	605	CARDINAL
ihlr-28381	339	2	81	CARDINAL
ihlr-28381	340	1	fed	ORG
ihlr-28381	341	1	581	CARDINAL
ihlr-28381	341	2	f. supp	PERSON
ihlr-28381	342	1	3d 579	CARDINAL
ihlr-28381	342	2	605	CARDINAL
ihlr-28381	342	3	2022	CARDINAL
ihlr-28381	343	1	82	CARDINAL
ihlr-28381	344	1	602	CARDINAL
ihlr-28381	345	1	83	CARDINAL
ihlr-28381	346	1	602-03	CARDINAL
ihlr-28381	347	1	84	CARDINAL
ihlr-28381	348	1	636	CARDINAL
ihlr-28381	349	1	richards et al.	PERSON
ihlr-28381	349	2	41	CARDINAL
ihlr-28381	349	3	1	CARDINAL
ihlr-28381	349	4	137	CARDINAL
ihlr-28381	350	1	fda	ORG
ihlr-28381	352	1	vi	PERSON
ihlr-28381	355	1	ftc	ORG
ihlr-28381	355	2	the supreme court	ORG
ihlr-28381	355	3	2013.86	CARDINAL
ihlr-28381	355	4	ftc	ORG
ihlr-28381	355	5	ftc	ORG
ihlr-28381	355	6	the supreme court	ORG
ihlr-28381	355	7	5	CARDINAL
ihlr-28381	356	1	patent.92	PERSON
ihlr-28381	357	1	compensation.94	ORG
ihlr-28381	358	1	ftc v. actavis	PERSON
ihlr-28381	358	2	inc.	ORG
ihlr-28381	358	3	570	CARDINAL
ihlr-28381	358	4	136	CARDINAL
ihlr-28381	358	5	141	DATE
ihlr-28381	358	6	2013	DATE
ihlr-28381	359	1	87	CARDINAL
ihlr-28381	360	1	158	CARDINAL
ihlr-28381	363	1	159	CARDINAL
ihlr-28381	363	2	91	CARDINAL
ihlr-28381	364	1	146-54	CARDINAL
ihlr-28381	365	1	92	CARDINAL
ihlr-28381	366	1	158	CARDINAL
ihlr-28381	367	1	93	CARDINAL
ihlr-28381	368	1	158	CARDINAL
ihlr-28381	369	1	94	CARDINAL
ihlr-28381	370	1	karas et al.	PERSON
ihlr-28381	370	2	supra	PERSON
ihlr-28381	370	3	50	CARDINAL
ihlr-28381	370	4	963	CARDINAL
ihlr-28381	371	1	138	CARDINAL
ihlr-28381	371	2	indiana health law review	ORG
ihlr-28381	374	1	justice roberts	PERSON
ihlr-28381	375	1	5-3	CARDINAL
ihlr-28381	375	2	ftc	ORG
ihlr-28381	376	1	decision.97	PERSON
ihlr-28381	377	1	1997	DATE
ihlr-28381	377	2	90%	PERCENT
ihlr-28381	377	3	time.99	LOC
ihlr-28381	378	1	one	CARDINAL
ihlr-28381	380	1	anda	PERSON
ihlr-28381	380	2	anda	PERSON
ihlr-28381	381	1	the supreme court	ORG
ihlr-28381	381	2	ftc	ORG
ihlr-28381	381	3	95	CARDINAL
ihlr-28381	382	1	feldman	PERSON
ihlr-28381	382	2	supra	PERSON
ihlr-28381	382	3	10	CARDINAL
ihlr-28381	382	4	13	CARDINAL
ihlr-28381	382	5	96	CARDINAL
ihlr-28381	383	1	actavis, inc.	ORG
ihlr-28381	383	2	u.s.	GPE
ihlr-28381	383	3	173	CARDINAL
ihlr-28381	383	4	97	CARDINAL
ihlr-28381	384	1	karas et al.	PERSON
ihlr-28381	384	2	supra	PERSON
ihlr-28381	384	3	50	CARDINAL
ihlr-28381	384	4	964	CARDINAL
ihlr-28381	385	1	98	CARDINAL
ihlr-28381	386	1	feldman	PERSON
ihlr-28381	386	2	supra	PERSON
ihlr-28381	386	3	10	CARDINAL
ihlr-28381	386	4	15	CARDINAL
ihlr-28381	386	5	99	CARDINAL
ihlr-28381	387	1	ncaa	ORG
ihlr-28381	388	1	v. alston	PERSON
ihlr-28381	388	2	141	CARDINAL
ihlr-28381	388	3	s. ct.	PERSON
ihlr-28381	388	4	2141	CARDINAL
ihlr-28381	388	5	2161	CARDINAL
ihlr-28381	388	6	2021	CARDINAL
ihlr-28381	389	1	100	CARDINAL
ihlr-28381	390	1	s. 1428	ORG
ihlr-28381	390	2	117th	CARDINAL
ihlr-28381	391	1	27(a)(2)(a)(ii	CARDINAL
ihlr-28381	391	2	senate	ORG
ihlr-28381	391	3	dec. 9	DATE
ihlr-28381	391	4	2021	DATE
ihlr-28381	392	1	2024	CARDINAL
ihlr-28381	392	2	139	CARDINAL
ihlr-28381	394	1	ftc	ORG
ihlr-28381	396	1	the supreme court	ORG
ihlr-28381	396	2	ftc	ORG
ihlr-28381	397	1	one	CARDINAL
ihlr-28381	399	1	years	DATE
ihlr-28381	399	2	congress	ORG
ihlr-28381	400	1	dozens	CARDINAL
ihlr-28381	402	1	congress	ORG
ihlr-28381	402	2	101	CARDINAL
ihlr-28381	403	1	richards et al.	PERSON
ihlr-28381	403	2	41	CARDINAL
ihlr-28381	403	3	102	CARDINAL
ihlr-28381	404	1	actavis, inc.	ORG
ihlr-28381	404	2	u.s.	GPE
ihlr-28381	404	3	136	CARDINAL
ihlr-28381	405	1	103	CARDINAL
ihlr-28381	405	2	35	CARDINAL
ihlr-28381	406	1	2022	CARDINAL
ihlr-28381	407	1	104	CARDINAL
ihlr-28381	408	1	actavis, inc.	ORG
ihlr-28381	408	2	u.s.	GPE
ihlr-28381	408	3	138	CARDINAL
ihlr-28381	408	4	105	CARDINAL
ihlr-28381	409	1	humira	ORG
ihlr-28381	409	2	adalimumab	PERSON
ihlr-28381	409	3	litig	PERSON
ihlr-28381	410	1	465	CARDINAL
ihlr-28381	411	1	3d 811	CARDINAL
ihlr-28381	411	2	834	CARDINAL
ihlr-28381	411	3	n.d.	GPE
ihlr-28381	411	4	2020	DATE
ihlr-28381	411	5	baltimore v. abbvie, inc.	ORG
ihlr-28381	411	6	42	CARDINAL
ihlr-28381	411	7	709	CARDINAL
ihlr-28381	411	8	7th	ORDINAL
ihlr-28381	411	9	2022	CARDINAL
ihlr-28381	411	10	brooktree corp.	ORG
ihlr-28381	411	11	advanced micro devices, inc.	ORG
ihlr-28381	411	12	977	CARDINAL
ihlr-28381	411	13	1555	DATE
ihlr-28381	411	14	1574	CARDINAL
ihlr-28381	411	15	fed	ORG
ihlr-28381	411	16	cir	ORG
ihlr-28381	411	17	1992	DATE
ihlr-28381	412	1	106	CARDINAL
ihlr-28381	413	1	richards et al.	PERSON
ihlr-28381	413	2	41	CARDINAL
ihlr-28381	414	1	140	CARDINAL
ihlr-28381	414	2	indiana health law review	ORG
ihlr-28381	415	1	vii	PERSON
ihlr-28381	416	1	two	CARDINAL
ihlr-28381	416	2	1	CARDINAL
ihlr-28381	416	3	fda	ORG
ihlr-28381	416	4	hundreds	CARDINAL
ihlr-28381	416	5	2	CARDINAL
ihlr-28381	418	1	fda	ORG
ihlr-28381	418	2	four months	DATE
ihlr-28381	418	3	ten months	DATE
ihlr-28381	418	4	six	CARDINAL
ihlr-28381	419	1	four months	DATE
ihlr-28381	419	2	four additional months	DATE
ihlr-28381	423	1	fda	ORG
ihlr-28381	424	1	appeal.110	ORG
ihlr-28381	424	2	fda	ORG
ihlr-28381	424	3	2007	DATE
ihlr-28381	424	4	107	CARDINAL
ihlr-28381	425	1	u.s.	GPE
ihlr-28381	425	2	251	CARDINAL
ihlr-28381	425	3	fda	ORG
ihlr-28381	425	4	jan. 2020	DATE
ihlr-28381	427	1	108	CARDINAL
ihlr-28381	428	1	u.s.	GPE
ihlr-28381	428	2	supra	PERSON
ihlr-28381	428	3	105	CARDINAL
ihlr-28381	428	4	2	CARDINAL
ihlr-28381	428	5	109	CARDINAL
ihlr-28381	428	6	food and drug administration	ORG
ihlr-28381	428	7	2007	DATE
ihlr-28381	430	1	110-85	CARDINAL
ihlr-28381	430	2	1102	DATE
ihlr-28381	430	3	121	CARDINAL
ihlr-28381	431	1	823	CARDINAL
ihlr-28381	431	2	972	CARDINAL
ihlr-28381	431	3	2007	DATE
ihlr-28381	431	4	food and drug administration	ORG
ihlr-28381	433	1	112	CARDINAL
ihlr-28381	433	2	908	CARDINAL
ihlr-28381	433	3	126	CARDINAL
ihlr-28381	434	1	993	CARDINAL
ihlr-28381	434	2	1094	DATE
ihlr-28381	434	3	2012	DATE
ihlr-28381	434	4	21st century	DATE
ihlr-28381	436	1	114	CARDINAL
ihlr-28381	436	2	3086	CARDINAL
ihlr-28381	436	3	130	CARDINAL
ihlr-28381	437	1	1033	CARDINAL
ihlr-28381	437	2	1145	CARDINAL
ihlr-28381	437	3	2016	DATE
ihlr-28381	437	4	u.s.	GPE
ihlr-28381	438	1	105	CARDINAL
ihlr-28381	439	1	110	CARDINAL
ihlr-28381	440	1	13-14	DATE
ihlr-28381	440	2	141	CARDINAL
ihlr-28381	440	3	prv	PERSON
ihlr-28381	440	4	$67.5 million to $350	MONEY
ihlr-28381	443	1	one	CARDINAL
ihlr-28381	444	1	fda	ORG
ihlr-28381	444	2	prvs	NORP
ihlr-28381	445	1	fda	ORG
ihlr-28381	446	1	fda	ORG
ihlr-28381	447	1	fda	ORG
ihlr-28381	448	1	fda	ORG
ihlr-28381	450	1	2009	DATE
ihlr-28381	450	2	prv	PERSON
ihlr-28381	450	3	2019	DATE
ihlr-28381	450	4	thirty-one	CARDINAL
ihlr-28381	450	5	seventeen	CARDINAL
ihlr-28381	450	6	sixteen	CARDINAL
ihlr-28381	450	7	prvs	NORP
ihlr-28381	450	8	2	CARDINAL
ihlr-28381	450	9	2113 111	DATE
ihlr-28381	452	1	u.s.	GPE
ihlr-28381	452	2	105	CARDINAL
ihlr-28381	452	3	113	CARDINAL
ihlr-28381	453	1	142	CARDINAL
ihlr-28381	453	2	indiana health law review	ORG
ihlr-28381	454	1	prv	PERSON
ihlr-28381	454	2	its fourteenth year	DATE
ihlr-28381	454	3	2023	CARDINAL
ihlr-28381	455	1	three	CARDINAL
ihlr-28381	456	1	3	CARDINAL
ihlr-28381	457	1	3114	CARDINAL
ihlr-28381	459	1	prv	PERSON
ihlr-28381	462	1	prv	PERSON
ihlr-28381	462	2	three	CARDINAL
ihlr-28381	463	1	prvs moot	PERSON
ihlr-28381	464	1	fda	ORG
ihlr-28381	465	1	fda	ORG
ihlr-28381	466	1	114	CARDINAL
ihlr-28381	467	1	15	CARDINAL
ihlr-28381	467	2	143	CARDINAL
ihlr-28381	467	3	fda	ORG
ihlr-28381	468	1	fda	ORG
ihlr-28381	468	2	prv	PERSON
ihlr-28381	469	1	november 2022	DATE
ihlr-28381	469	2	$102 million	MONEY
ihlr-28381	469	3	bluebird bio	PERSON
ihlr-28381	469	4	fda	ORG
ihlr-28381	469	5	four months.115	QUANTITY
ihlr-28381	469	6	january 2023	DATE
ihlr-28381	469	7	fda	ORG
ihlr-28381	469	8	fda	ORG
ihlr-28381	469	9	march 20	DATE
ihlr-28381	469	10	2023 to june 20	DATE
ihlr-28381	469	11	2023	CARDINAL
ihlr-28381	470	1	fda	ORG
ihlr-28381	470	2	japan	GPE
ihlr-28381	471	1	first	ORDINAL
ihlr-28381	471	2	$97 million	MONEY
ihlr-28381	471	3	four months	DATE
ihlr-28381	471	4	fda	ORG
ihlr-28381	471	5	february 22	DATE
ihlr-28381	471	6	2023.117	CARDINAL
ihlr-28381	471	7	february	DATE
ihlr-28381	471	8	17	CARDINAL
ihlr-28381	471	9	just five days	DATE
ihlr-28381	471	10	fda	ORG
ihlr-28381	471	11	three months	DATE
ihlr-28381	471	12	22	DATE
ihlr-28381	471	13	2023	CARDINAL
ihlr-28381	473	1	3,340,000	CARDINAL
ihlr-28381	473	2	each year	DATE
ihlr-28381	473	3	between $2,000 and $2,500	MONEY
ihlr-28381	473	4	three-month	DATE
ihlr-28381	473	5	hundreds of millions of dollars	MONEY
ihlr-28381	474	1	prv	PERSON
ihlr-28381	475	1	fda	ORG
ihlr-28381	475	2	congress	ORG
ihlr-28381	476	1	115	CARDINAL
ihlr-28381	477	1	nicole defeudis	PERSON
ihlr-28381	477	2	100m+	MONEY
ihlr-28381	477	3	fda	ORG
ihlr-28381	477	4	bluebird bio	PERSON
ihlr-28381	477	5	(nov. 30	DATE
ihlr-28381	477	6	2022	CARDINAL
ihlr-28381	479	1	116	CARDINAL
ihlr-28381	480	1	jan. 27	DATE
ihlr-28381	480	2	2023	CARDINAL
ihlr-28381	481	1	117	CARDINAL
ihlr-28381	482	1	katherine lewin	PERSON
ihlr-28381	482	2	fda	ORG
ihlr-28381	482	3	97	MONEY
ihlr-28381	482	4	feb. 21	DATE
ihlr-28381	482	5	2023	CARDINAL
ihlr-28381	484	1	118	CARDINAL
ihlr-28381	485	1	u.s.	GPE
ihlr-28381	485	2	pr newswire	ORG
ihlr-28381	485	3	feb. 19	DATE
ihlr-28381	485	4	2023	CARDINAL
ihlr-28381	487	1	119	CARDINAL
ihlr-28381	488	1	francesca l. beaudoin et al.	PERSON
ihlr-28381	490	1	rev	PERSON
ihlr-28381	491	1	58	DATE
ihlr-28381	491	2	dec. 1	DATE
ihlr-28381	491	3	2022	CARDINAL
ihlr-28381	493	1	144	CARDINAL
ihlr-28381	493	2	indiana health law review	ORG
ihlr-28381	494	1	prv	PERSON
ihlr-28381	494	2	gao	PERSON
ihlr-28381	494	3	gao	PERSON
ihlr-28381	494	4	prv value	PERSON
ihlr-28381	494	5	fda	ORG
ihlr-28381	498	1	u.s.	GPE
ihlr-28381	498	2	u.s.	GPE
ihlr-28381	500	1	fda	ORG
ihlr-28381	501	1	years	DATE
ihlr-28381	502	1	20%	PERCENT
ihlr-28381	502	2	first 180 days	DATE
ihlr-28381	502	3	120	CARDINAL
ihlr-28381	503	1	u.s.	GPE
ihlr-28381	503	2	105	CARDINAL
ihlr-28381	504	1	121	CARDINAL
ihlr-28381	505	1	29	CARDINAL
ihlr-28381	506	1	122	CARDINAL
ihlr-28381	507	1	123	CARDINAL
ihlr-28381	508	1	kurt karst	PERSON
ihlr-28381	508	2	fda	ORG
ihlr-28381	508	3	sep. 29, 2014	DATE
ihlr-28381	510	1	124	CARDINAL
ihlr-28381	511	1	feldman & frondorf	ORG
ihlr-28381	511	2	21	CARDINAL
ihlr-28381	511	3	500-01	CARDINAL
ihlr-28381	511	4	2024	CARDINAL
ihlr-28381	511	5	145	CARDINAL
ihlr-28381	514	1	fda	ORG
ihlr-28381	518	1	wildcards	PERSON
ihlr-28381	520	1	first	ORDINAL
ihlr-28381	521	1	three	CARDINAL
ihlr-28381	522	1	first	ORDINAL
ihlr-28381	522	2	greater than	DATE
ihlr-28381	522	3	14 years	DATE
ihlr-28381	523	1	second	ORDINAL
ihlr-28381	524	1	fda	ORG
ihlr-28381	525	1	third	ORDINAL
ihlr-28381	526	1	at least 12 years	DATE
ihlr-28381	526	2	fewer than 16 years	DATE
ihlr-28381	527	1	greater than 16 years	DATE
ihlr-28381	527	2	one	CARDINAL
ihlr-28381	527	3	three	CARDINAL
ihlr-28381	528	1	three	CARDINAL
ihlr-28381	528	2	125	CARDINAL
ihlr-28381	530	1	42	CARDINAL
ihlr-28381	531	1	2022	CARDINAL
ihlr-28381	532	1	127	CARDINAL
ihlr-28381	533	1	42	CARDINAL
ihlr-28381	534	1	1320f-3(c)(5	CARDINAL
ihlr-28381	534	2	2022	CARDINAL
ihlr-28381	535	1	128	CARDINAL
ihlr-28381	538	1	146	CARDINAL
ihlr-28381	538	2	indiana	GPE
ihlr-28381	539	1	wildcards	ORG
ihlr-28381	540	1	wildcards	ORG
ihlr-28381	541	1	no later than two years	DATE
ihlr-28381	541	2	fda	ORG
ihlr-28381	543	1	years-long	DATE
ihlr-28381	547	1	5	MONEY
ihlr-28381	548	1	the years	DATE
ihlr-28381	548	2	5	MONEY
ihlr-28381	550	1	fda	ORG
ihlr-28381	550	2	hhs	ORG
ihlr-28381	552	1	hatch-waxman	ORG
ihlr-28381	554	1	129	CARDINAL
ihlr-28381	555	1	aug. 2021	DATE
ihlr-28381	557	1	147	CARDINAL
ihlr-28381	557	2	first	ORDINAL
ihlr-28381	562	1	fda	ORG
ihlr-28381	566	1	prv	PERSON
ihlr-28381	567	1	first	ORDINAL
ihlr-28381	567	2	second	ORDINAL
ihlr-28381	567	3	fda	ORG
ihlr-28381	569	1	sec	ORG
ihlr-28381	570	1	fda	ORG
ihlr-28381	571	1	fda	ORG
ihlr-28381	571	2	six months	DATE
ihlr-28381	571	3	130	CARDINAL
ihlr-28381	572	1	114	CARDINAL
ihlr-28381	572	2	lewin	GPE
ihlr-28381	572	3	supra	PERSON
ihlr-28381	572	4	115	CARDINAL
ihlr-28381	573	1	148	CARDINAL
ihlr-28381	573	2	indiana health law review	ORG
ihlr-28381	573	3	1	CARDINAL
ihlr-28381	573	4	2	CARDINAL
ihlr-28381	573	5	3	CARDINAL
ihlr-28381	574	1	wildcards	PERSON
ihlr-28381	574	2	first	ORDINAL
ihlr-28381	574	3	first	ORDINAL
ihlr-28381	578	1	billions of dollars	MONEY
ihlr-28381	578	2	u.s.	GPE
ihlr-28381	578	3	annual	DATE
ihlr-28381	578	4	$3.5 billion to $37	MONEY
ihlr-28381	579	1	two	CARDINAL
ihlr-28381	579	2	one	CARDINAL
ihlr-28381	580	1	annual	DATE
ihlr-28381	580	2	billions	CARDINAL
ihlr-28381	580	3	americans	NORP
ihlr-28381	582	1	american	NORP
ihlr-28381	582	2	131	CARDINAL
ihlr-28381	583	1	u.s.	GPE
ihlr-28381	583	2	105	CARDINAL
ihlr-28381	584	1	132	CARDINAL
ihlr-28381	585	1	feldman	PERSON
ihlr-28381	585	2	supra	PERSON
ihlr-28381	585	3	10	CARDINAL
ihlr-28381	585	4	32-33	DATE
ihlr-28381	586	1	133	CARDINAL
ihlr-28381	589	1	supra	PERSON
ihlr-28381	589	2	6	CARDINAL
ihlr-28381	589	3	149	CARDINAL